PGNY PROGYNY
Health Care · Russell 2000
Next earnings: not announced yet
What 14 analyst firms say about PROGYNY: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
11 rated views · 15 analyst/firm records · 14 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Average target is not above the current price
- Russell 2000 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 14 reports on PGNY from 11 analyst firms in the last 90 days (15 firms in the past year).
Comparing each firm's latest target with its previous one: 6 raised their price target, 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Cantor Fitzgerald raised its target from $31.00 (set 15 Jun 2026) to $35.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Glen Santangelo | Hold | 28 Jul 2026 | Conflicting reports · excluded |
| Barclays | Peter Warendorf | Hold | 12 Aug 2026 | 30.00 USD |
| BTIG | David Larsen | Buy | 24 Jul 2026 | 40.00 USD |
| Canaccord Genuity | Richard Close | — | 7 Aug 2026 | 35.00 USD |
| Cantor Fitzgerald | Sarah James | Buy | 15 Jun 2026 | 31.00 USD |
| Citigroup | Unnamed analyst | Buy | 8 Sep 2026 | — |
| Citizens JMP | Constantine Davides | Buy | 8 Sep 2026 | 33.00 USD |
| Jefferies | Brian Tanquilut | — | 8 Sep 2026 | 33.00 USD |
| JPMorgan | Lisa Gill | Hold | 21 Aug 2026 | 30.00 USD |
| KeyBanc Capital Markets | Scott Schoenhaus | Buy | 13 Jul 2026 | 35.00 USD |
| Leerink Partners | Michael Cherny | ConflictConflicting reports · excluded | 22 Jul 2026 | Conflicting reports · excluded |
| Truist | Jailendra Singh | Buy | 13 Aug 2026 | 36.00 USD |
| Weiss Ratings | Unnamed analyst | — | 8 Oct 2026 | — |
| Wells Fargo | Stan Berenshteyn | Buy | 30 Sep 2026 | 37.00 USD |
| Data feed RESEARCH | Research Team | Hold | 19 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:57 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.